Wanted pages

Jump to navigation Jump to search

List of non-existing pages with the most links to them, excluding pages which only have redirects linking to them. For a list of non-existent pages that have redirects linking to them, see the list of broken redirects.

Showing below up to 50 results in range #451 to #500.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Lodelcizumab (2 links)
  2. Lokivetmab (2 links)
  3. Lorvotuzumab mertansine (2 links)
  4. Lucatumumab (2 links)
  5. Lulizumab pegol (2 links)
  6. Lumiliximab (2 links)
  7. Lumretuzumab (2 links)
  8. Lutetium (177 Lu) lilotomab satetraxetan (2 links)
  9. Lymphoma (2 links)
  10. Lymphotoxin alpha (2 links)
  11. MABp1 (2 links)
  12. MCP-1 (2 links)
  13. MS4A1 (2 links)
  14. MUC1 (2 links)
  15. Macrophage migration inhibitory factor (2 links)
  16. Macular degeneration (2 links)
  17. Mapatumumab (2 links)
  18. Margetuximab (2 links)
  19. Maslimomab (2 links)
  20. Matuzumab (2 links)
  21. Mavrilimumab (2 links)
  22. Melanoma (2 links)
  23. Mepolizumab (2 links)
  24. Mesothelin (2 links)
  25. Metelimumab (2 links)
  26. Migraine (2 links)
  27. Milatuzumab (2 links)
  28. Minretumomab (2 links)
  29. Mirvetuximab soravtansine (2 links)
  30. Mitumomab (2 links)
  31. Mogamulizumab (2 links)
  32. Monalizumab (2 links)
  33. Morolimumab (2 links)
  34. Motavizumab (2 links)
  35. Moxetumomab pasudotox (2 links)
  36. Mucin (2 links)
  37. Multiple myeloma (2 links)
  38. Multiple sclerosis (2 links)
  39. Muromonab-CD3 (2 links)
  40. Muscle atrophy (2 links)
  41. Myosin (2 links)
  42. Myostatin (2 links)
  43. Nacolomab tafenatox (2 links)
  44. Namilumab (2 links)
  45. Naptumomab estafenatox (2 links)
  46. Naratuximab emtansine (2 links)
  47. Narnatumab (2 links)
  48. Nasopharyngeal cancer (2 links)
  49. Natalizumab (2 links)
  50. Navicixizumab (2 links)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://eln.excellgen.com/index.php?title=Special:WantedPages"